Bronchogenic cyst
diseaseOn this page
Also known as bronchogenic cyst (disease)
Summary
Bronchogenic cyst (MONDO:0016523) is a disease and 1 clinical trial. Top therapeutic interventions include ropivacaine. A subtype of respiratory system disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: Unknown (Worldwide)
- ClinVar variants: 1
- Phenotypes (HPO): 33
- Clinical trials: 1
Clinical features
Signs & symptoms
Clinical features (HPO)
33 HPO clinical features (Orphanet curated; top 33 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0100730 | Bronchogenic cyst | Obligate (100%) |
| HP:0031983 | Abnormal pulmonary thoracic imaging finding | Frequent (30-79%) |
| HP:0045026 | Abnormality of the mediastinum | Frequent (30-79%) |
| HP:0001945 | Fever | Occasional (5-29%) |
| HP:0002031 | Abnormal esophagus morphology | Occasional (5-29%) |
| HP:0002090 | Pneumonia | Occasional (5-29%) |
| HP:0002094 | Dyspnea | Occasional (5-29%) |
| HP:0003319 | Abnormality of the cervical spine | Occasional (5-29%) |
| HP:0012735 | Cough | Occasional (5-29%) |
| HP:0031035 | Chronic infection | Occasional (5-29%) |
| HP:0032016 | Abnormal sputum | Occasional (5-29%) |
| HP:0032445 | Pulmonary cyst | Occasional (5-29%) |
| HP:0100749 | Chest pain | Occasional (5-29%) |
| HP:0000464 | Abnormality of the neck | Very rare (<1-4%) |
| HP:0000775 | Abnormality of the diaphragm | Very rare (<1-4%) |
| HP:0001324 | Muscle weakness | Very rare (<1-4%) |
| HP:0001637 | Abnormal myocardium morphology | Very rare (<1-4%) |
| HP:0001697 | Abnormal pericardium morphology | Very rare (<1-4%) |
| HP:0002015 | Dysphagia | Very rare (<1-4%) |
| HP:0002027 | Abdominal pain | Very rare (<1-4%) |
| HP:0002103 | Abnormality of the pleura | Very rare (<1-4%) |
| HP:0002105 | Hemoptysis | Very rare (<1-4%) |
| HP:0002315 | Headache | Very rare (<1-4%) |
| HP:0002577 | Abnormal stomach morphology | Very rare (<1-4%) |
| HP:0002585 | Abnormality of the peritoneum | Very rare (<1-4%) |
| HP:0002699 | Abnormality of the foramen magnum | Very rare (<1-4%) |
| HP:0003396 | Syringomyelia | Very rare (<1-4%) |
| HP:0003401 | Paresthesia | Very rare (<1-4%) |
| HP:0003418 | Back pain | Very rare (<1-4%) |
| HP:0010766 | Ectopic calcification | Very rare (<1-4%) |
| HP:0030833 | Neck pain | Very rare (<1-4%) |
| HP:0100712 | Abnormal lumbar spine morphology | Very rare (<1-4%) |
| HP:0100750 | Atelectasis | Very rare (<1-4%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | bronchogenic cyst |
| Mondo ID | MONDO:0016523 |
| MeSH | D001994 |
| Orphanet | 2357 |
| ICD-11 | 355400995 |
| UMLS | C0006281 |
| MedGen | 668 |
| GARD | 0001025 |
| MedDRA | 10064585 |
| Is cancer (heuristic) | no |
Also known as: bronchogenic cyst · bronchogenic cyst (disease)
Data availability: 1 ClinVar variant · 1 HPO phenotype.
Disease family
This is a subtype of respiratory system disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › respiratory system disorder › bronchogenic cyst
Related subtypes (58): lower respiratory tract disorder, respiratory system cancer, respiratory system benign neoplasm, allergic respiratory disease, paranasal sinus disorder, upper respiratory tract disorder, pertussis, severe acute respiratory syndrome, sleep apnea syndrome, diaphragm disorder, pulmonary tuberculosis, altitude sickness, perinatal asphyxia, pulmonary nodular lymphoid hyperplasia, tracheobronchopathia osteochondroplastica, Williams-Campbell syndrome, cystic fibrosis, growth delay-hydrocephaly-lung hypoplasia syndrome, laryngo-onycho-cutaneous syndrome, congenital pulmonary lymphangiectasia, familial primary pulmonary hypoplasia, Mounier-Kuhn syndrome, Young syndrome, lung agenesis-heart defect-thumb anomalies syndrome, sudden infant death-dysgenesis of the testes syndrome, alpha 1-antitrypsin deficiency, hereditary sclerosing poikiloderma with tendon and pulmonary involvement, autoimmune interstitial lung disease-arthritis syndrome, mucopolysaccharidosis-plus syndrome, congenital bronchobiliary fistula, primary ciliary dyskinesia, congenital pulmonary airway malformation, transient hyperammonemia of the newborn, congenital pulmonary sequestration, Siegler-Brewer-Carey syndrome, tracheal agenesis, 16q24.1 microdeletion syndrome, staphylococcal necrotizing pneumonia, pulmonary veno-occlusive disease and/or pulmonary capillary haemangiomatosis, plastic bronchitis, recurrent respiratory papillomatosis, IgG4-related mediastinitis, bronchopulmonary dysplasia, infantile apnea, diffuse alveolar hemorrhage, respiratory or thoracic malformation, pulmonary agenesis, eosinophilic granuloma, disorder of pharynx, respiratory tract neoplasm, pulmonary alveolar proteinosis with hypogammaglobulinemia, respiratory tract infectious disorder, Middle East respiratory syndrome, reactive airway disease, acinar dysplasia, pulmonary hypoplasia, isolated left bronchial isomerism, bronchiectasis and nasal polyposis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
1 retrieved; paginated sample, class counts are floors:
1 uncertain significance
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 267908 | 46;XY;t(3;18)(q13.2;q11.2)dn | Uncertain significance | criteria provided, single submitter |
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06498583 | Not specified | COMPLETED | Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Pain and Sleep Quality of Infants With Congenital Pulmonary Cystic Disease After Thoracoscopic Surgery |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| ROPIVACAINE | 4 | 1 |
Related Atlas pages
- Drugs: Ropivacaine